Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
Clinical trial NCT00829049 · TERMINATED
Trial details
- NCT number
- NCT00829049
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-10-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.